Large-scale testing (Phase 3)Study completedNCT01326026
What this trial is testing
Comparing the Efficacy and Safety of NN1250 Once Daily When Titrated Using 2 Different Algorithms in Insulin naïve Subjects With Type 2 Diabetes Mellitus
Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 222